16 June 2020: Clinical Research
Effects of Valsartan on Restenosis in Patients with Arteriosclerosis Obliterans of the Lower Extremities Undergoing Interventional Therapy: A Prospective, Randomized, Single-Blind Trial
Wei Yao 1ABE , Lixin Wang 2AB* , Qing Chen 1BC , Fang Wang 1CD , Nana Feng 1EFDOI: 10.12659/MSM.919977
Med Sci Monit 2020; 26:e919977
Table 2 Comparison of the clinical efficacies between the 2 groups.
| Cases | Cure | Significantly effective | Effective | Ineffective | Total effective rate | χ2 | P | |
|---|---|---|---|---|---|---|---|---|
| ARB group | 98 | 21.4% (21) | 50.0% (49) | 25.5% (25) | 2.7% (3) | 97.95% | 9.094 | 0.003 |
| Control group | 96 | 13.5% (13) | 25.0% (24) | 45.8% (44) | 15.6% (15) | 84.37% | ||